Biallelic RPE65 Mutation-associated Retinal Dystrophy
Oncology
3 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| luxturna | Spark Therapeutics, Inc. (SPARK) |
Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Biallelic RPE65 Mutation-associated Retinal Dystrophy?
BioSniper tracks 3 drugs in development for Biallelic RPE65 Mutation-associated Retinal Dystrophy across 2 companies.
How many clinical trials target Biallelic RPE65 Mutation-associated Retinal Dystrophy?
There are 1 clinical trial targeting Biallelic RPE65 Mutation-associated Retinal Dystrophy tracked by BioSniper.
Deep-dive into Biallelic RPE65 Mutation-associated Retinal Dystrophy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis